Prolonged Disease Stabilization and Tolerability in a Nuclear Protein in Testis Midline Carcinoma Patient Treated with Dual Histone Deacetylase and Phosphoinositide 3-Kinase Inhibitor CUDC-907

ISSN Print: 2325-7075
ISSN Online: 2325-7083
www.scirp.net/journal/crcm
E-mail: [email protected]

Citations

"Prolonged Disease Stabilization and Tolerability in a Nuclear Protein in Testis Midline Carcinoma Patient Treated with Dual Histone Deacetylase and Phosphoinositide 3-Kinase Inhibitor CUDC-907"
written by Pamela Munster, Nilson Wu, Meaghan McMahon, Robert Gharavi, David Tuck,
published by Case Reports in Clinical Medicine, Vol.7 No.7, 2018

has been cited by the following article(s):

[1]	Nuclear protein in testis carcinoma of the lung
	Translational Oncology, 2023

[2]	Immunotherapy experience in sinonasal NUT midline carcinoma, case report
	Journal of Cancer …, 2023

[3]	Sinonasal NUT Carcinoma: Delayed Diagnosis Due to the COVID-19 Pandemic and a Review of the Literature
	2021

[4]	Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease
	2020

[5]	NUT midline carcinoma of the head and neck: current perspectives
	2019

[1]	Immunotherapy experience in sinonasal NUT midline carcinoma, case report Journal of Cancer Research and Therapeutics, 2024 DOI:10.4103/jcrt.jcrt_1083_22

[2]	Nuclear protein in testis carcinoma of the lung Translational Oncology, 2023 DOI:10.1016/j.tranon.2023.101640

[3]	Sinonasal NUT Carcinoma: Delayed Diagnosis Due to the COVID-19 Pandemic and a Review of the Literature Head and Neck Pathology, 2021 DOI:10.1007/s12105-021-01311-x

[4]	Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease The Journal of Clinical Endocrinology & Metabolism, 2021 DOI:10.1210/clinem/dgaa699

Top